Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Hyaluronic acid is a substance that is naturally present in the human body. It is found in the highest concentrations in fluids in the eyes and joints. People take hyaluronic acid for various joint disorders, including osteoarthritis. It can be taken by mouth or injected into the affected joint by a healthcare professional. The FDA has approved the use of hyaluronic acid during certain eye surgeries including cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. It is injected into the eye during the procedure to help replace natural fluids. The American Society of Plastic Surgeons (ASAPS) added hyaluronic acid (HA) to their annual survey in 2004, and in 2013 it was the most popular wrinkle filler used in America.
The hyaluronic acid market has shown sustainable growth owing to rising demand for non-invasive and minimal invasive cosmetic procedures and increasing concern of the people towards their looks and appearance. Likewise, the expansion of the product portfolio coupled with increasing number of applications is further anticipated to boost the market over the forecast period. However, high cost of the products and complications associated with the cosmetic use of hyaluronic acid is predicted to restrict the growth of the global market over the forecast period.
The report analyses the hyaluronic acid market based on application and geography.
Based on application, this hyaluronic acid market is classified into dermal fillers, osteoarthritis, ophthalmic and vesicoureteral reflux. The osteoarthritis segment is further segmented into single injection, three injection and five injection. In 2018. The dermal filler application segment accounted for the largest share of the global hyaluronic acid market. The largest share of the segment is primarily attributed to rising demand from cosmetic industry as hyaluronic acid hydrates the skin and is mostly used option for antiaging treatment. Currently many beauty brands are adding hyaluronic acid in serums and creams for beauty enhancement.
Geographically, the global hyaluronic acid market is categorized into North America, Europe, Asia Pacific and Rest of the World. Rest of the world comprises of Latin America and Middle East & Africa. North America is the leading market holding the major regional share in 2018 as consumers in this region give more importance to anti-aging treatments such as plastic surgery. This in turn, will drive the demand for hyaluronic acid (HA) in the region. Moreover, the adoption of HA will also increase with the growing instances of osteoarthritis. Meanwhile, Asia Pacific is projected to grow at a faster pace over the forecast period. The growth is propelled by vast improvements in the healthcare sector in recent years. In addition, the growing popularity of minimally invasive surgeries is a key trend expected to accentuate the regional market.
Key players of the global hyaluronic acid market are ALLERGAN, Sanofi, Genzyme Corporation, F.hoffmann-la Roche Ltd, Zimmer Biomet, Smith & Nephew Plc, Ferring Pharmaceuticals Inc, Anika Therapeutics Inc, Salix Pharmaceuticals, Lifecore Biomedical, LLC, etc. The hyaluronic acid market is characterized by the presence of many established international and regional players. These vendors are adopting strategic mergers and acquisitions to expand their geographical network. They are also investing in research and developmental activities to implement innovative technologies and launch novel product variants. This will in turn, help them enhance their revenue share in the global market.
Hyaluronic acid is naturally formed in connective tissue throughout a human body with 50 percent found in the skin. It is one of the major components of the extracellular matrix and it also play an important role in retaining moisture in the skin. Due to its hydrophobic nature hyaluronic acid is used for treatment of osteoarthritis. Whereas hyaluronic acid is also used to replace body fluid during surgeries of retina, cornea and cataract. The report analyses the hyaluronic acid market based on application and geography. Based on application, this hyaluronic acid market is classified into dermal fillers, osteoarthritis, ophthalmic and vesicoureteral reflux. Major players of this market are funding for research and new product development to derive effective solution to the market. Innovative and advanced product development are key factors for global hyaluronic acid market. Due to its rapid growth rate, many new companies are getting attracted towards this market. Geographically, the global hyaluronic acid market is categorized into North America, Europe, Asia Pacific and Rest of the World. Rest of the world comprises of Latin America and Middle East & Africa. North America is the leading market holding the major regional share in 2018 as consumers in this region give more importance to anti-aging treatments such as plastic surgery. This in turn, will drive the demand for hyaluronic acid (HA) in the region. Key players of the global hyaluronic acid market are ALLERGAN, Sanofi, Genzyme Corporation, F.hoffmann-la Roche Ltd, Zimmer Biomet, Smith & Nephew Plc, Ferring Pharmaceuticals Inc, Anika Therapeutics Inc, Salix Pharmaceuticals, Lifecore Biomedical, LLC, etc.
Why to buy this report:
